Back Pain, Musculoskeletal Pain, Post-COVID-19 Syndrome
Conditions
Brief summary
Objective: This study aims to compare and evaluate the effectiveness of kinesiotaping and traditional physiotherapy methods, which are frequently used in the treatment of musculoskeletal diseases, on mid-back pain (MBP) developed after COVID-19. Study Design and Methods: Patients aged 18 or older who have been diagnosed with COVID-19, have completed their medical treatment, and whose isolation period has ended are included in the study. The patients' age, sex, and body mass index (BMI) are recorded. The participants are assigned to receive one of two interventions. In the first group, kinesiotapes are applied and left on the patient's back for a total of 10 days. The second group is treated with traditional physiotherapy methods, specifically Vacuum Interferential Current Therapy and Hot Pack Therapy. Clinical evaluations are performed using the Visual Analogue Scale (VAS), Pain Quality Assessment Scale, LANSS Neuropathic Pain Scale, and Nottingham Extended Activities of Daily Living Index. Measurements are taken at two time points: baseline (pre-treatment) and at the end of the 10th day (post-treatment).,
Interventions
Application of 5x5 cm Kinesio Tape with a slight stretch of approximately 10 to 15% on the painful back area during trunk flexion and contralateral rotation.
Application of hot packs and vacuum interferential current therapy using diagonally placed vacuum electrodes (Intelect Mobile Combo®, USA) to encompass the pain area.
Sponsors
Study design
Masking description
To minimize bias, the researcher who performed the baseline and post-treatment clinical assessments (VAS, NEADLS, LANSS) was blinded to the patients' group allocations.
Intervention model description
Eligible patients were randomly assigned to either the Kinesiotaping group or the Physiotherapy group in a 1:1 ratio for parallel interventions lasting 10 days
Eligibility
Inclusion criteria
* Patients aged 18 years and older. * Patients experiencing mechanical mid-back pain (MBP) that developed after recovering from a confirmed COVID-19 infection. * Volunteering to participate in the study and providing written informed consent.
Exclusion criteria
* History of previous spinal surgery or spinal trauma. * Presence of structural spinal deformities (e.g., severe kyphosis or scoliosis). * Presence of radicular pain, neurological deficits, or suspected disc herniation. * Active infection, malignancy, or severe systemic inflammatory diseases. * Known skin allergy or dermatological conditions preventing the application of Kinesio Tape. * Pregnancy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain Intensity assessed by Visual Analogue Scale (VAS) | Baseline (Pre-treatment) and Day 10 (Post-treatment) | The Visual Analogue Scale (VAS) is used to evaluate the patient's mid-back pain intensity under three conditions: at rest, at night, and during activity/exercise. The scale is a 10 cm line where 0 represents "no pain" and 10 represents "the worst imaginable pain." Higher scores indicate greater pain severity. |
Countries
Turkey (Türkiye)